Wedbush Adjusts Avalo Therapeutics Price Target to $22 From $34, Maintains Outperform Rating
MT newswire2026/10/22 16:21Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
12:21 PM EDT, 10/22/2026 (MT Newswires) -- Avalo Therapeutics (AVTX) has an average rating of buy and mean price target of $46.18, according to analysts polled by FactSet. Price: 7.85, Change: -4.41, Percent Change: -35.97
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
National Grid (NGG.US) raises full-year profit forecast as capital investment soars to £6.7 billions, £70 billions upgrade plan enters acceleration phase
The UK National Grid has released its semi-annual report for the period ending September 30, 2026, and has raised its full-year profit forecast.
智通财经•2026/11/05 08:36
Brent: Election-driven risk premium unwinds – ING
FXStreet•2026/11/05 08:12
Crypto prices
More
Bitcoin
BTC
$80,421.31
+2.60%
Ethereum
ETH
$2,417.78
+4.01%
Tether USDt
USDT
$0.9990
+0.04%
BNB
BNB
$714.97
+1.84%
XRP
XRP
$1.32
+3.19%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$96.48
+3.45%
TRON
TRX
$0.3181
-1.18%
Zcash
ZEC
$1,316.61
+1.98%
Hyperliquid
HYPE
$83.84
-2.70%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now